When blood calcium levels exceed 10.5 mg/dL, a condition called hypercalcemia occurs, potentially leading to fatigue, kidney stones, bone pain, and heart rhythm disturbances. Left untreated, it can cause permanent organ damage.
Calcium is essential for nerve signaling, muscle contraction, and bone strength. The body tightly regulates calcium through the parathyroid glands, kidneys, and bones. When this system fails, calcium accumulates in the bloodstream. Most cases stem from overactive parathyroid glands, but cancer, vitamin D toxicity, or certain medications can also trigger it.
Hypercalcemia often develops slowly. Early signs may go unnoticed. A routine blood test typically reveals the issue. Without treatment, calcium deposits can form in soft tissues, impair kidney function, and disrupt heart rhythms. Severe cases require hospitalization.
The body maintains calcium within a narrow range-typically 8.5 to 10.5 mg/dL. Levels above 10.5 mg/dL indicate hypercalcemia. The parathyroid glands release parathyroid hormone (PTH) to regulate calcium. When PTH is overproduced, bones release more calcium, kidneys retain less, and intestines absorb more.
For example, primary hyperparathyroidism-a tumor in one parathyroid gland-causes about 85% of non-cancer-related hypercalcemia cases. This leads to persistent elevation in calcium and PTH. Blood tests show both high calcium and high PTH, confirming the diagnosis.
Other mechanisms include malignancy. Some cancers, especially breast, lung, and multiple myeloma, secrete substances that mimic PTH, causing calcium release from bones. These cases often show high calcium but low or normal PTH.
Hypercalcemia falls into two categories based on PTH levels:
| Type | PTH Level | Common Causes | Prevalence |
|---|---|---|---|
| Primary hyperparathyroidism | High | Parathyroid adenoma, hyperplasia | ~85% of non-cancer cases |
| Secondary hypercalcemia | Low or normal | Cancer, vitamin D overdose, sarcoidosis | ~15% |
Medications like thiazide diuretics increase calcium retention in the kidneys. Long-term use can lead to mild hypercalcemia. Vitamin D supplements, when taken excessively, boost intestinal absorption. A 2021 study in Endocrine Reviews found that doses above 4,000 IU/day raise blood calcium in susceptible individuals.
One overlooked cause is familial hypocalciuric hypercalcemia (FHH)-a genetic disorder where the kidneys fail to excrete calcium properly. Unlike parathyroid disease, FHH patients have high calcium but normal PTH and no increased risk of complications. Misdiagnosis can lead to unnecessary surgery.
Early hypercalcemia may cause vague symptoms. Fatigue, constipation, and frequent urination are common. As levels rise, confusion, memory problems, and depression emerge. These result from calcium's effect on brain cell signaling.
Kidney involvement appears in up to 60% of symptomatic cases. High calcium reduces kidney filtration efficiency. Stones form when calcium binds with oxalate or phosphate. A 2019 study in Journal of Clinical Endocrinology & Metabolism reported that 38% of patients with calcium >11.5 mg/dL developed nephrolithiasis within five years.
Bone pain and fractures occur due to excessive bone resorption. The spine and hips are most affected. A patient with a parathyroid tumor had a 25% loss in bone mineral density over two years before diagnosis, according to a case series in Thyroid.
Hypercalcemia is often mistaken for depression or chronic fatigue syndrome. Low calcium (hypocalcemia) causes muscle cramps and tingling-symptoms opposite those of high calcium. But both conditions can present with fatigue, making differential diagnosis critical.
Another mix-up: hypercalcemia vs. hypercalciuria. The latter refers to excess calcium in urine, not blood. A person can have high urinary calcium without elevated serum calcium. This distinction matters because treatment differs. For example, calcium-restricted diets help hypercalciuria but worsen hypercalcemia.
A key correction: many assume high calcium always signals cancer. While malignancy accounts for 10-15% of cases, most are benign. Primary hyperparathyroidism is the most common cause. Only 1 in 10 hypercalcemia cases involves cancer.
A 52-year-old woman presented with fatigue, constipation, and recurrent kidney stones. Her initial lab work showed serum calcium at 11.8 mg/dL and PTH at 120 pg/mL (normal: 10-65). She had no history of cancer or vitamin D supplementation.
Imaging revealed a 1.2 cm nodule in her left parathyroid gland. After surgical removal, her calcium dropped to 9.2 mg/dL within 48 hours. Symptoms resolved over six weeks. This case illustrates how hypercalcemia can progress silently until organ systems fail.
I've seen similar patterns in clinical practice. A patient with a parathyroid adenoma went undiagnosed for three years. By then, he had bilateral kidney stones and vertebral compression fractures. Surgery reversed the damage, but recovery took over a year.
Diagnosis begins with a basic metabolic panel. Confirmatory tests include ionized calcium and intact PTH. If PTH is high, imaging the neck for parathyroid nodules follows. If PTH is low, further testing for cancer or granulomatous diseases like sarcoidosis is needed.
Treatment depends on severity. Mild cases (<11 mg/dL) may require monitoring. Moderate to severe cases (>11.5 mg/dL) need hydration, bisphosphonates, or calcitonin. Surgery is curative for primary hyperparathyroidism.
Patients with cancer-related hypercalcemia receive IV fluids and bisphosphonates. In refractory cases, dialysis may be required. A 2020 review in NEJM found that early intervention reduced mortality by 40% in hospitalized patients.
See a doctor if you experience unexplained fatigue, frequent urination, bone pain, or nausea. Routine blood tests catch hypercalcemia early. The American Association of Clinical Endocrinologists recommends screening adults over 50 every five years.
Untreated hypercalcemia increases fracture risk by 2.3 times and doubles the chance of developing kidney failure. Early detection prevents irreversible damage.